RT @IreneNorstedt: 🦟What’s buzzin’ in #vaccine research💉

@valnevaSE's phase 3 trial results on its single-dose vaccine for #Chikungunya🦟 funded by @CEPIvaccines with #H2020 support were published in @TheLancet 👏

Read here about this great advancement👇👇
https://t.co/32uy1GtRNJ https://t.co/pqgL02N4xC

🐦🔗: https://n.respublicae.eu/EU_HaDEA/status/1668630298446401545